Key Insights

Highlights

Treatment Research

1 treatments under study, led by Fostamatinib

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05904093Phase 1Recruiting

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Showing all 1 trials

Research Network

Common Treatments

  • Fostamatinib1

Active Sponsors

  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Sickle Cell Disorders1
  • Sickle Cell Disease1
  • Hemoglobin S1
  • Hbss Disease1

Activity Timeline